Andrew T. Bender

4.1k total citations · 1 hit paper
56 papers, 3.1k citations indexed

About

Andrew T. Bender is a scholar working on Molecular Biology, Immunology and Physiology. According to data from OpenAlex, Andrew T. Bender has authored 56 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 20 papers in Immunology and 12 papers in Physiology. Recurrent topics in Andrew T. Bender's work include Chronic Lymphocytic Leukemia Research (9 papers), Nitric Oxide and Endothelin Effects (8 papers) and Biosensors and Analytical Detection (8 papers). Andrew T. Bender is often cited by papers focused on Chronic Lymphocytic Leukemia Research (9 papers), Nitric Oxide and Endothelin Effects (8 papers) and Biosensors and Analytical Detection (8 papers). Andrew T. Bender collaborates with scholars based in United States, Germany and Italy. Andrew T. Bender's co-authors include Joseph A. Beavo, Yoichi Osawa, Damon R. Demady, Jonathan D. Posner, Suree Jianmongkol, Albertina Pereira, William B. Pratt, Kimon C. Kanelakis, Roland Grenningloh and Soichi Noguchi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Andrew T. Bender

55 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use

2006 1.4k citations Andrew T. Bender et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andrew T. Bender United States	24	1.9k	555	499	457	315	56	3.1k
Xuesong Chen China	35	1.6k 0.8×	502 0.9×	272 0.5×	184 0.4×	141 0.4×	193	3.8k
Paul Schaeffer France	27	1.8k 0.9×	1.3k 2.4×	292 0.6×	400 0.9×	579 1.8×	73	3.9k
Masakazu Hirata Japan	25	1.5k 0.7×	1.1k 2.0×	1.6k 3.2×	518 1.1×	431 1.4×	50	4.3k
Kazem Zibara Lebanon	35	1.9k 1.0×	289 0.5×	109 0.2×	469 1.0×	340 1.1×	147	3.9k
Juan Miguel Redondo Spain	51	3.8k 2.0×	617 1.1×	567 1.1×	1.4k 3.2×	526 1.7×	135	6.7k
Jian‐Yuan Zhao China	37	1.8k 0.9×	891 1.6×	208 0.4×	471 1.0×	223 0.7×	148	4.0k
Pengfei Li China	39	2.5k 1.3×	319 0.6×	160 0.3×	688 1.5×	140 0.4×	214	4.8k
Osamu Hazeki Japan	36	2.9k 1.5×	658 1.2×	166 0.3×	1.3k 2.8×	263 0.8×	89	5.4k
Hiroyuki Satoh Japan	27	2.9k 1.5×	997 1.8×	139 0.3×	286 0.6×	491 1.6×	152	4.9k
Gennady G. Yegutkin Finland	41	1.7k 0.9×	350 0.6×	109 0.2×	961 2.1×	332 1.1×	83	5.2k

Countries citing papers authored by Andrew T. Bender

Since Specialization

Citations

This map shows the geographic impact of Andrew T. Bender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew T. Bender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew T. Bender more than expected).

Fields of papers citing papers by Andrew T. Bender

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew T. Bender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew T. Bender. The network helps show where Andrew T. Bender may publish in the future.

Co-authorship network of co-authors of Andrew T. Bender

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew T. Bender. A scholar is included among the top collaborators of Andrew T. Bender based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew T. Bender. Andrew T. Bender is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bender, Andrew T., et al.. (2024). Vibration mixing for enhanced paper-based recombinase polymerase amplification. Lab on a Chip. 24(20). 4879–4891. 2 indexed citations

Bender, Andrew T., et al.. (2024). SARS-CoV-2 recombinase polymerase amplification assay with lateral flow readout and duplexed full process internal control. Sensors & Diagnostics. 3(3). 421–430. 3 indexed citations

Wu, Yin, Nicholas Geraci, Petra Budde, et al.. (2024). TLR7/8 Activation in Immune Cells and Muscle by RNA‐Containing Immune Complexes: Role in Inflammation and the Pathogenesis of Myositis. Arthritis & Rheumatology. 77(2). 190–201. 6 indexed citations

Lin, Jing, Andrew T. Bender, Albertina Pereira, et al.. (2023). Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies. Scientific Reports. 13(1). 20412–20412. 5 indexed citations

Pereira, Albertina, Nicholas Geraci, Evgeni P. Tzvetkov, et al.. (2023). Preclinical Evidence for the Glucocorticoid-Sparing Potential of a Dual Toll-Like Receptor 7/8 Inhibitor in Autoimmune Diseases. Journal of Pharmacology and Experimental Therapeutics. 388(3). 751–764. 10 indexed citations

Morand, Eric F., Victoria P. Werth, Andrew T. Bender, et al.. (2022). 1501 Enpatoran: preclinical evidence supporting glucocorticoid dose reduction and Phase II study design in patients with SLE and/or CLE (WILLOW). SHILAP Revista de lepidopterología. A93–A94.

Bender, Andrew T., Lorraine Lillis, Wynn Burke, et al.. (2022). Rapid detection of hepatitis C virus using recombinase polymerase amplification. PLoS ONE. 17(10). e0276582–e0276582. 10 indexed citations

Bender, Andrew T., Ayokunle O. Olanrewaju, Lorraine Lillis, et al.. (2022). HIV pre-exposure prophylaxis adherence test using reverse transcription isothermal amplification inhibition assay. Analytical Methods. 14(13). 1361–1370. 1 indexed citations

Olanrewaju, Ayokunle O., et al.. (2022). REverSe TRanscrIptase chain termination ( RESTRICT ) for selective measurement of nucleotide analogs used in HIV care and prevention. Bioengineering & Translational Medicine. 8(1). e10369–e10369. 4 indexed citations

10.

Bender, Andrew T., et al.. (2022). Quantitative isothermal amplification on paper membranes using amplification nucleation site analysis. Lab on a Chip. 22(12). 2352–2363. 12 indexed citations

11.

Bender, Andrew T., et al.. (2021). Current state of commercial point-of-care nucleic acid tests for infectious diseases. The Analyst. 146(8). 2449–2462. 28 indexed citations

12.

Bender, Andrew T., et al.. (2021). HIV detection from human serum with paper-based isotachophoretic RNA extraction and reverse transcription recombinase polymerase amplification. The Analyst. 146(9). 2851–2861. 23 indexed citations

13.

Bender, Andrew T., et al.. (2020). Enzymatic and Chemical-Based Methods to Inactivate Endogenous Blood Ribonucleases for Nucleic Acid Diagnostics. Journal of Molecular Diagnostics. 22(8). 1030–1040. 21 indexed citations

14.

Hatz, Sonja, Scott Spangler, Andrew T. Bender, et al.. (2019). Identification of pharmacodynamic biomarker hypotheses through literature analysis with IBM Watson. PLoS ONE. 14(4). e0214619–e0214619. 8 indexed citations

15.

Drain, Paul K., Jienchi Dorward, Andrew T. Bender, et al.. (2019). Point-of-Care HIV Viral Load Testing: an Essential Tool for a Sustainable Global HIV/AIDS Response. Clinical Microbiology Reviews. 32(3). 79 indexed citations

16.

Ma, Jianguo, et al.. (2017). M7583 Is a Highly Selective and Potent Second Generation BTK Inhibitor for Treatment of B-Cell Malignancies. Blood. 130. 3845–3845. 4 indexed citations

17.

Bender, Andrew T., A.S. Gardberg, Albertina Pereira, et al.. (2017). Ability of Bruton’s Tyrosine Kinase Inhibitors to Sequester Y551 and Prevent Phosphorylation Determines Potency for Inhibition of Fc Receptor but not B-Cell Receptor Signaling. Molecular Pharmacology. 91(3). 208–219. 126 indexed citations

18.

Bender, Andrew T., Albertina Pereira, Kai Fu, et al.. (2016). Btk inhibition treats TLR7/IFN driven murine lupus. Clinical Immunology. 164. 65–77. 38 indexed citations

19.

Noguchi, Soichi, Suree Jianmongkol, Andrew T. Bender, et al.. (2000). Guanabenz-mediated Inactivation and Enhanced Proteolytic Degradation of Neuronal Nitric-oxide Synthase. Journal of Biological Chemistry. 275(4). 2376–2380. 48 indexed citations

20.

Bender, Andrew T., Damon R. Demady, & Yoichi Osawa. (2000). Ubiquitination of Neuronal Nitric-oxide Synthase in Vitro and in Vivo. Journal of Biological Chemistry. 275(23). 17407–17411. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact